| Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632) |
|---|
| 07/29/2004 | WO2004063683A1 Real time spectral image analysis device and analysis method |
| 07/29/2004 | WO2004063662A1 Sensor for measuring film properties |
| 07/29/2004 | WO2004063394A2 Uses of substances binding to fabp4 for diagnosing and treating bladder carcinoma |
| 07/29/2004 | WO2004063387A2 Fluorescent silica-based nanoparticles |
| 07/29/2004 | WO2004063371A1 Protein complex, process for producing the same and use thereof |
| 07/29/2004 | WO2004063368A1 Method of detecting drug-resistance gene contained in tubercle bacillus, primer pair set for pcr, primer set for determining base sequence and reagent kit for diagnnosing drug-resistant tuberculosis |
| 07/29/2004 | WO2004063362A2 Cell cycle progression proteins |
| 07/29/2004 | WO2004063355A2 Novel methods of diagnosis of metastatic cancer, compositions and methods of screening for modulators of matastatic cancer |
| 07/29/2004 | WO2004063354A2 Compositions and methods for characterizing and regulating wnt pathways |
| 07/29/2004 | WO2004063349A2 Lysozyme transgenic ungulates |
| 07/29/2004 | WO2004063337A2 Kunitz domain library |
| 07/29/2004 | WO2004063224A1 Novel lysophosphatidic acid receptor |
| 07/29/2004 | WO2004063215A2 Improve peptide charge state assignment in a high-throughput ms/ms environment |
| 07/29/2004 | WO2004062801A1 Multi-layered electrochemical microfluidic sensor comprising reagent on porous layer |
| 07/29/2004 | WO2004062783A2 Multi-phase fluid sampling method and apparatus |
| 07/29/2004 | WO2004062686A2 Therapeutic use of modulators of notch |
| 07/29/2004 | WO2004062675A1 Method of modulating il-6 |
| 07/29/2004 | WO2004062627A2 In vivo screening models for treatment of alzheimer's disease and other neurodegenerative disorders |
| 07/29/2004 | WO2004062608A2 Cancer comprehensive assay kit for identifying cancer protein patterns |
| 07/29/2004 | WO2004062572A2 Determining the density of functional moieties on polymer reagents |
| 07/29/2004 | WO2004062570A2 Apparatus and method to measure platelet contractility |
| 07/29/2004 | WO2004062567A2 Arterivirus marker vaccine |
| 07/29/2004 | WO2004062563A2 Methods for screening for therapeutic agents that are useful in the treatment of oxytocin and vasopressin-related disorders |
| 07/29/2004 | WO2004062553A2 Affinity screening using “one-bead-one-compound” libraries |
| 07/29/2004 | WO2004062483A2 Cancer comprehensive method for identifying cancer protein patterns and determination of cancer treatment strategies |
| 07/29/2004 | WO2004062475A2 Fluorescent assays for protein kinases |
| 07/29/2004 | WO2004062472A2 System and method for in vitro bleeding time testing |
| 07/29/2004 | WO2004062462A2 Monclonal anitbodies to rna binding protein gw182 |
| 07/29/2004 | WO2004054428A3 Nor-1 (neuron-derived orphan receptor-1), novel diagnostic and therapeutic target for cardiovascular diseases |
| 07/29/2004 | WO2004050614A3 Flavanols and procyanidins promote homeostasis |
| 07/29/2004 | WO2004047866A3 Use of the corticoliberin-urocortin system in the treatment of inflammatory diseases |
| 07/29/2004 | WO2004045379A3 Biomarkers for intra-amniotic inflammation |
| 07/29/2004 | WO2004044001A3 Acetylated hmgb1 protein |
| 07/29/2004 | WO2004042403A3 Methods, device and instrument for detection of analytes |
| 07/29/2004 | WO2004041061A8 Substrates, devices, and methods for cellular assays |
| 07/29/2004 | WO2004039963A8 Antibodies specific for phosphorylated insulin receptor substrate-1/2 (ser 1101/ser1149) and uses thereof |
| 07/29/2004 | WO2004038412A3 Method for detecting halitosis |
| 07/29/2004 | WO2004038368A3 Device and method for monitoring leukocyte migration |
| 07/29/2004 | WO2004036176A3 Biosensor |
| 07/29/2004 | WO2004034063A3 Detecting apparatus |
| 07/29/2004 | WO2004034054A3 Method for enhancing and prolonging the bioluminescence resonance energy transfer (bret) signal in a bret assay and a substrate solution for use in a bret assay |
| 07/29/2004 | WO2004032609A3 Systems and methods for rapidly and accurately identifying live eggs within a stream of eggs |
| 07/29/2004 | WO2004029217A3 Method for screening molecular interactions |
| 07/29/2004 | WO2004028692A3 Supporting element for conducting diagnostic tests |
| 07/29/2004 | WO2004020978A3 Formation of metal nanowires for use as variable-range hydrogen sensors |
| 07/29/2004 | WO2004020655A3 Food pathogen sensor using molecularly imprinted polymers |
| 07/29/2004 | WO2004015392A3 Improved method to identify targeting molecules |
| 07/29/2004 | WO2004008151A3 New combinatorial peptide libraries containing markers and methods for their preparation and utilization |
| 07/29/2004 | WO2003104181A3 Compounds that abrogate dna-damage-induced cell cycle g2 checkpoint and/or augment the anti-cancer activity of dna-damaging treatments |
| 07/29/2004 | WO2003103579A3 High-throughput methods and systems for screening of compounds to treat/prevent kidney disorders |
| 07/29/2004 | WO2003103481A3 Methods for detecting b. anthracis infection |
| 07/29/2004 | WO2003102158A3 Methods for increasing bone density |
| 07/29/2004 | WO2003099783A3 Tropane compounds |
| 07/29/2004 | WO2003098212B1 Method of isolating an endotehelial cell and method of donor specific crossmatching |
| 07/29/2004 | WO2003095515A3 A method to rapidly prepare and screen formulations and compositions containing same |
| 07/29/2004 | WO2003089927A3 Antigens associated with haematological malignancy |
| 07/29/2004 | WO2003087831A3 Proteins involved in breast cancer |
| 07/29/2004 | WO2003087766A3 Methods of diagnosing potential for metastasis or developing hepatocellular carcinoma and of identifying therapeutic targets |
| 07/29/2004 | WO2003083138A3 Methods of evaluating dna-based links |
| 07/29/2004 | WO2003078598A3 Methods for using bag expression as a cell differentiation agent and marker |
| 07/29/2004 | WO2003077870A3 New strains of mycoplasma hyorhinis as causative agents for autoimmune disease |
| 07/29/2004 | WO2003075741A3 METHODS OF PREVENTING OR TREATING DISORDERS BY ADMINISTERING AN INTEGRIN αvβ3 ANTAGONIST IN COMBINATION WITH AN HMG-CoA REDUCTASE INHIBITOR OR A BISPHOSPHONATE |
| 07/29/2004 | WO2003074990A3 Artificial receptors, building blocks, and methods |
| 07/29/2004 | WO2003069348A3 USE OF MIP-3α AND ITS RECEPTOR TO TREAT ARTHRITIS |
| 07/29/2004 | WO2003068915A3 Production of human antibodies in immunodeficient, non-human, mammalian hosts |
| 07/29/2004 | WO2003068803A3 A nucleic acid encoding a g-protein-coupled receptor, and uses thereof |
| 07/29/2004 | WO2003059951A8 Novel anti-igf-ir antibodies and uses thereof |
| 07/29/2004 | WO2003050544A8 Methods for protein analysis using protein capture arrays |
| 07/29/2004 | WO2003050541A3 Diagnosis of malaria by identifying autoantibodies that react against calreticulin |
| 07/29/2004 | WO2003025150A3 Lipid-associated molecules |
| 07/29/2004 | WO2003011209A3 Methods of sensitizing hepatocyte cell cultures to hepatitis infection, beads coated with hbv or hcv polypeptides and methods of using such beads to model viral infection or deliver substances into hepatocytes |
| 07/29/2004 | WO2002066971A3 Method for detecting metal nucleating substances |
| 07/29/2004 | US20040148112 Method and device for evaluating processability of viscoelastic material, method for setting condition for processing viscoelastic material, and device for processing viscoelastic material; and method for controlling processing operation of viscoelastic material |
| 07/29/2004 | US20040148107 Method and system for evaluating properties of a beverage |
| 07/29/2004 | US20040148105 Computational method for predicting protein interaction sites |
| 07/29/2004 | US20040147904 Methods and devices for delivery of agents to breast milk ducts |
| 07/29/2004 | US20040147885 Skin permeable gas collector and skin permeable gas measuring apparatus |
| 07/29/2004 | US20040147854 Instrument for use in collecting and recovering liquid secretion in oral cavity |
| 07/29/2004 | US20040147747 Longer wavelength absorption than structurally similar dyes; staining; ligand and analyte detection; aromatic or heteroaromatic ring fused at 3,4-double bond |
| 07/29/2004 | US20040147727 Compounds, compositions and methods for the treatment of diseases characterized by A-33 related antigens |
| 07/29/2004 | US20040147724 for diagnosis/treatment of cancer, myeloproliferative disorders, angiogenesis, obesity, osteoporosis, non-insulin dependent diabetes, lipid metabolism disorder, hypercalcemia, hypercholestrolemia; genetic engineering |
| 07/29/2004 | US20040147719 Type III bacterial strains for use in medicine |
| 07/29/2004 | US20040147582 Use of etodolac for the treatment of chronic lymphocytic leukemia |
| 07/29/2004 | US20040147530 Urogenital disorders; dysmenorrhea; endometriosis; anticancer agents |
| 07/29/2004 | US20040147450 To promote bone growth in mammals |
| 07/29/2004 | US20040147432 Melanin-concentrating hormone analogs |
| 07/29/2004 | US20040147429 Endogenous, constitutively activated G protein-coupled orphan receptors |
| 07/29/2004 | US20040147386 Device and method for separation of blood components |
| 07/29/2004 | US20040147045 Signal molecule arrays |
| 07/29/2004 | US20040147044 Antigens |
| 07/29/2004 | US20040147042 Device for precise chemical delivery and solution preparation |
| 07/29/2004 | US20040147041 comprises a test chamber formed by a base part and a head part and means for moving the sample in the test chamber pumps are connected via channels a portion of the sample liquid is alternately drawn off and supplied back |
| 07/29/2004 | US20040147040 Multidimensional separation of biosubstance mixtures for mass spectrometric analysis |
| 07/29/2004 | US20040147038 for halitosis, periodontal disease, vaginitis, and ovulation; comprises contacting an array of sensors with mammalian breath suspected of containing a marker gas |
| 07/29/2004 | US20040147037 using an ultraviolet light source and by sealing in a circuit arrangement that prevents adsorption; for molecular sensors, nanotube-based molecular electronics and optoelectronic devices |
| 07/29/2004 | US20040147033 ultra-sensitive methods for detecting changes in glycosylation that are correlated with pre-cancerous or early cancerous states using blood, serum, semen, feces or saliva; for prognosis/drug screening |
| 07/29/2004 | US20040147032 Microsystem for determining clotting time of blood and low-cost, single-use device for use therein |
| 07/29/2004 | US20040147031 having a coating layer on the surface with nanoparticles present, enabling the functional beads to emit light specific to the nanoparticles by applying a voltage to the functional beads in flow path; flow cytometry |
| 07/29/2004 | US20040147030 Transgenic animals for monitoring water quality |
| 07/29/2004 | US20040147004 Comprises nucleotide sequences coding enzymatic polypeptide for use as tool in identifying modulators for diagnosis, treatment and prevention of cancer and cell proliferative disorders |